Dynamic Technology Lab Private LTD Chemo Centryx, Inc. Transaction History

Dynamic Technology Lab Private LTD

$914 Million
Q3 2024

Shares

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 Nov 14, 2022	BUY	$22.17 - $51.8 $648,428 - $1.52 Million	29,248 Added 326.43%	38,208 $1.97 Million
Q2 2022 Aug 12, 2022	BUY	$15.36 - $27.51 $137,625 - $246,489	8,960 New	8,960 $222,000
Q1 2022 May 16, 2022	SELL	$22.22 - $39.12 $133,919 - $235,776	-6,027 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$18.38 - $40.5 $110,776 - $244,093	6,027 New	6,027 $219,000
Q3 2020 Nov 13, 2020	SELL	$46.35 - $61.69 $194,670 - $259,098	-4,200 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$38.58 - $65.07 $162,036 - $273,294	4,200 New	4,200 $242,000
Q2 2018 Aug 14, 2018	SELL	$10.62 - $13.98 $119,411 - $157,191	-11,244 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$5.9 - $14.99 $66,339 - $168,547	11,244 New	11,244 $153,000

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.